Feline immunodeficiency virus vaccination: characterization of the immune correlates of protection.
Whole inactivated virus (WIV) vaccines derived from the FL4 cell line protect cats against challenge with feline immunodeficiency virus (FIV). To investigate the correlates of protective immunity induced by WIV, we established an immunization regimen which protected a proportion of the vaccinates against challenge. A strong correlation was observed between high virus neutralizing antibody titers and protection following challenge. To investigate further the immune mechanisms responsible for immunity, all of the vaccinates were rechallenged 35 weeks following the initial challenge. Results of virus isolation from peripheral blood mononuclear cells indicated that 9 of 10 vaccinates were protected from viremia following the second challenge, suggesting that vaccine-induced immunity to FIV persisted for at least 8 months. However, more stringent analysis for evidence of infection revealed that 5 of 10 vaccinates harbored virus in lymphoid tissues. Unlike the protection observed immediately following vaccination, which correlated positively with virus neutralizing antibody titer, the ability to resist a second challenge with FIV was more closely correlated with the induction of Env-specific cytotoxic T-cell activity. The results indicate that both virus-specific humoral immunity and cellular immunity play a role in the protection induced in cats by WIV immunization but their relative importance may be dependent on the interval between vaccination and exposure to virus.
Hosie
M J
MJ
MRC Retrovirus Research Laboratory, Department of Veterinary Pathology, University of Glasgow, Bearsden, United Kingdom. m.hosie@vet.gla.ac.uk.
Flynn
J N
JN
D000595:Amino Acid Sequence; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D000956:Antigens, Viral / Q000276:immunology*; D002415:Cats; D002460:Cell Line; D015683:Gene Products, gag / Q000276:immunology; D016089:Immunodeficiency Virus, Feline / Q000276:immunology*; D007156:Immunologic Memory; D016180:Lentivirus Infections / Q000517:prevention & control*; D008198:Lymph Nodes / Q000276:immunology; D008221:Lymphoid Tissue / Q000821:virology; D008969:Molecular Sequence Data; D013602:T-Lymphocytes, Cytotoxic; D013997:Time Factors; D014611:Vaccination; D014759:Viral Envelope Proteins / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology*
D000914:Antibodies, Viral; D000956:Antigens, Viral; D015683:Gene Products, gag; D014759:Viral Envelope Proteins; D014765:Viral Vaccines; C079587:p15(gag) protein, Feline immunodeficiency virus; C074661:p17 protein, feline immunodeficiency virus; C074662:p24 protein, Feline immunodeficiency virus